Skip to main content
letter
. 2020 Apr 23;24:170. doi: 10.1186/s13054-020-02893-8

Table 1.

Demographic, comorbidities, epidemiological characteristics, and clinical and laboratory findings of patients with confirmed COVID-19 at admission

Variables Total (n = 92) Mild-moderate at admission Severe at admission (n = 30) P value*
Persistent mild-moderate during hospitalization (n = 51) Mild-moderate to severe during hospitalization (n = 11) P value# Total (n = 62)
Demographic data
 Age (years) 55 ± 16 49 ± 13 59 ± 17 0.032 51 ± 15 63 ± 16 0.001
 Sex
  Male 57 (62%) 26 (51%) 8 (72.7%) 34 (54.8%) 23 (76.7%)
  Female 35 (38%) 25 (49%) 3 (27.3%) 0.189 28 (45.2%) 7 (23.3%) 0.043
 Occupation
  Agricultural worker 45 (48.9%) 25 (49%) 7 (63.6%) 32 (51.6%) 13 (43.3%)
  Self-employed 21 (22.8%) 15 (29.4%) 2 (18.7%) 17 (27.4%) 4 (13.3%)
  Employee 8 (8.7%) 5 (9.8%) 0 (0%) 5 (8.1%) 3 (10%)
  Retired 17 (18.5%) 5 (9.8%) 2 (18.2%) 7 (11.3%) 10 (33.3%)
  Students 1 (1.1%) 1 (2%) 0 (0%) 0.669 1 (1.6%) 0 (0%) 0.082
 Smoking history
  Yes 16 (17.4%) 7 (13.7%) 3 (27.3%) 17 (27.4%) 6 (20%)
  No 76 (82.6%) 44 (86.3%) 8 (72.7%) 0.268 45 (72.6%) 24 (80%) 0.441
Comorbidities
 Hypertension 33 (35.9%) 10 (19.6%) 7 (63.6%) 0.003 17 (27.4%) 16 (53.3%) 0.016
 Diabetes 9 (9.8%) 1 (2%) 2 (18.2%) 0.024 3 (4.8%) 6 (20%) 0.022
 Cardiovascular disease 8 (8.7%) 2 (3.9%) 1 (9.1%) 0.472 3 (4.8%) 5 (16.7%) 0.060
 Chronic liver diseases 4 (4.3%) 2 (3.9%) 1 (9.1%) 0.472 3 (4.8%) 1 (3.3%) 0.741
 Chronic renal diseases 3 (3.3%) 0 (0%) 1 (9.1%) 0.031 1 (1.6%) 2 (6.7%) 0.203
 Others 6 (6.5%) 0 (0%) 2 (18.2%) 0.002 2 (3.2%) 4 (13.3%) 0.067
Epidemiological characteristics
 Exposure to confirmed cases 46 (50%) 30 (58.8%) 5 (45.5%) 0.421 35 (56.5%) 11 (36.7%) 0.077
 Family cluster 27 (29.3%) 15 (29.4%) 4 (36.4%) 0.653 19 (30.6%) 8 (26.7%) 0.696
 Recent travel or residence to/in epidemic area 25 (27.2%) 11 (21.6%) 4 (36.4%) 0.303 15 (24.2%) 10 (33.3%) 0.358
Signs and symptoms
 Fever 84 (91.3%) 45 (88.2%) 11 (100%) 0.235 56 (90.3%) 28 (93.3%) 0.633
 Cough 58 (63%) 32 (62.7%) 7 (63.6%) 0.956 39 (62.9%) 13 (43.3%) 0.968
 Fatigue 6 (6.5%) 1 (2%) 2 (18.2%) 0.024 3 (4.8%) 3 (10%) 0.350
 Diarrhea 7 (7.6%) 1 (2%) 1 (9.1%) 0.229 2 (3.2%) 5 (16.7%) 0.023
 Nausea and vomiting 4 (4.3%) 3 (5.9%) 1 (9.1%) 0.697 4 (6.5%) 0 (0%) 0.157
 Shortness of breath 25 (27.2%) 2 (3.9%) 4 (36.4%) 0.001 6 (9.7%) 19 (63.3%) < 0.001
 Time to admission 3 (4) 4 (3) 1 (4) 0.011 4 (4) 1 (4) 0.211
 Time to confirmed diagnosis 5 (5) 5 (4) 4 (4) 0.160 5 (4) 3 (6) 0.239
Laboratory parameters
 WBC 6.5 (5.9) 5.2 (4.1) 7.5 ± 3.4 0.188 5.4 (4.5) 10.8 ± 5.6 < 0.001
 Lymphocyte 0.8 (0.6) 0.97 ± 0.47 0.7 (0.4) 0.147 0.9 (0.7) 0.5 (0.5) 0.001
 Platelet 191 (76) 193 (83) 170 ± 56 0.159 192 (84) 191 ± 45 0.851
 CRP 27 (37) 13 (27) 37 ± 27 0.036 16 (30) 39 (29) < 0.001
 ALT 23 (22) 23 (24) 17 (15) 0.338 22 (23) 23 (16) 0.723
 AST 22 (16) 21 (12) 21 (18) 1.000 21 (12) 26 (23) 0.236
 Cr 75 (25) 71 ± 26 84 (39) 0.054 73 (28) 84 (33) 0.019
 INR 0.98 (0.09) 0.97 ± 0.08 0.97 (0.04) 0.507 0.97 ± 0.06 1.01 ± 0.09 0.050
 Bilirubin 10.8 (6.0) 12.2 (5.0) 10.0 (6.0) 0.912 10.6 (5.0) 12.6 (9.0) 0.097
 LDH 281 ± 105 227 (103) 279 ± 101 0.376 229 (113) 339 (121) < 0.001
 CK 70 (76) 63 (61) 76 (60) 0.495 64 (58) 97 (172) 0.011
 Urea nitrogen 5.3 (3.7) 4.4 (1.7) 6.8 (6.9) < 0.001 4.6 (2.2) 7.7 (4.2) < 0.001
 CT scan
  Normal 3 (3.3%) 3 (5.9%) 0 (0%) 3 (4.8%) 0 (0%)
  Local lesion 5 (5.4%) 4 (7.8%) 0 (0%) 4 (6.5%) 1 (3.3%)
  Multi-lesions 84 (91.3%) 44 (86.3%) 11 (100%) 1.000 55 (88.7%) 29 (96.7%) 1.000
 ICU admission 27 (29.3%) 0 (0%) 8 (72.7%) < 0.001 8 (12.9%) 19 (63.3%) < 0.001

Data are expressed as number (percent), mean ± standard deviation (SD), or median (IQR)

#P values comparing data between patients becoming severe and those who did not during hospitalization by the Mann-Whitney U test, chi-squared test, or Fisher’s exact test

*P values comparing data between mild-moderate patients and severe patients at admission